Latest news with #098.50
Business Insider
4 days ago
- Business
- Business Insider
Alkem Laboratories Ltd. (ALKEM) Receives a Buy from Nomura
Nomura analyst Saion Mukherjee maintained a Buy rating on Alkem Laboratories Ltd. (ALKEM – Research Report) yesterday and set a price target of INR5,430.00. The company's shares closed last Friday at INR5,098.50. Confident Investing Starts Here: Mukherjee covers the Healthcare sector, focusing on stocks such as Alkem Laboratories Ltd., Cipla Ltd, and Fortis Healthcare Ltd.. According to TipRanks, Mukherjee has an average return of 12.5% and a 35.71% success rate on recommended stocks. In addition to Nomura, Alkem Laboratories Ltd. also received a Buy from ICICI Securities's Abdulkader Puranwala in a report issued on May 30. However, on the same day, J.P. Morgan maintained a Hold rating on Alkem Laboratories Ltd. (NSE: ALKEM). The company has a one-year high of INR6,440.00 and a one-year low of INR4,409.90. Currently, Alkem Laboratories Ltd. has an average volume of 2,117.
Business Insider
4 days ago
- Business
- Business Insider
Jefferies Sticks to Their Sell Rating for Alkem Laboratories Ltd. (ALKEM)
Jefferies analyst Alok Dalal maintained a Sell rating on Alkem Laboratories Ltd. (ALKEM – Research Report) on May 30 and set a price target of INR4,460.00. The company's shares closed last Friday at INR5,098.50. Confident Investing Starts Here: According to TipRanks, Dalal is a 2-star analyst with an average return of 2.0% and a 50.00% success rate. Dalal covers the Healthcare sector, focusing on stocks such as Ajanta Pharma Limited, Alkem Laboratories Ltd., and Cipla Ltd. Currently, the analyst consensus on Alkem Laboratories Ltd. is a Moderate Sell with an average price target of INR4,947.50. Based on Alkem Laboratories Ltd.'s latest earnings release for the quarter ending June 30, the company reported a quarterly revenue of INR30.32 billion and a net profit of INR5.45 billion. In comparison, last year the company earned a revenue of INR29.68 billion and had a net profit of INR2.87 billion
Business Insider
26-04-2025
- Business
- Business Insider
Partners Group Holding AG (PGHN) was upgraded to a Hold Rating at Kepler Capital
Partners Group Holding AG (PGHN – Research Report) received a Hold rating and a CHF1,200.00 price target from Kepler Capital analyst Nicolas Payen on April 24. The company's shares closed yesterday at CHF1,098.50. Stay Ahead of the Market: Discover outperforming stocks and invest smarter with Top Smart Score Stocks. Filter, analyze, and streamline your search for investment opportunities using Tipranks' Stock Screener. According to TipRanks, Payen is a 5-star analyst with an average return of 10.2% and a 62.23% success rate. The word on The Street in general, suggests a Hold analyst consensus rating for Partners Group Holding AG with a CHF1,194.88 average price target, representing an 8.77% upside. In a report released on April 15, Citi also downgraded the stock to a Hold with a CHF1,120.00 price target.
